The study evaluates the patient related risk and predictive factors concerning perioperative homologous blood cell transfusion (erythrocyte concentrate ) in THA patients in one EndoCert max-certified orthopedic hospital in Germany. A patient oriented preoperative decision-making algorithm (a personalised Patient Blood Management or pPBM App) will be developed as a new patient-safety blood-sparing strategy. The aim is to increase the patient safety by using the pPBM App and to reach a more efficient management of resources.
Retrospective audit of 470 consecutive primary THA in 2013 and 2014
Study Type
OBSERVATIONAL
Enrollment
477
Krankenhaus der Barmherzigen Brüder Trier
Trier, Rhineland-Palatinate, Germany
Events and circumstances of Homologous Blood Transfusion (erythrocyte concentrate transfusion)
Multivariate analysis of predictive variables like age, sex, BMI, hip and belly circumference, chronic kidney disease, chronic cardio-vascular disease, chronic inflammatory disease, diabetes mellitus, cancer, ASA Score, cemented, hybrid or not cemented prosthesis, surgery duration, medication and hemoglobin level before surgery
Time frame: participants will be followed for the duration of hospital stay, an expected average of 10 days
pPBM Computer Simulation
Introducing the pPBM App as a safe blood-sparing strategy
Time frame: participants will be followed for the duration of hospital stay, an expected average of 10 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.